Qube Research & Technologies (QRT)
XFOR icon

Qube Research & Technologies (QRT)’s X4 Pharmaceuticals XFOR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$904K Buy
218,954
+151,207
+223% +$566K ﹤0.01% 2540
2025
Q4 		$271K Buy
+67,747
New +$246K ﹤0.01% 2978

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Qube Research & Technologies (QRT)'s XFOR Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its X4 Pharmaceuticals (XFOR) stake by 223% in Q1 2026, buying an estimated $566K and bringing the position to 218,954 shares worth $904K. The position accounts for ﹤0.01% of the portfolio, ranked #2540.

Qube Research & Technologies (QRT) first reported a position in XFOR in Q4 2025 and has held it in 2 quarters since. 84 funds tracked by Wall St. Rank hold XFOR as of Q1 2026.

  • Qube Research & Technologies (QRT) held 218,954 shares of X4 Pharmaceuticals worth $904K as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 151,207 X4 Pharmaceuticals shares in Q1 2026, an estimated $566K.
  • X4 Pharmaceuticals made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2540 holding.
  • Qube Research & Technologies (QRT) first reported a position in X4 Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 84 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.